CD20+FCRL4+ B Cells Activate CD8+ T Cells via MHC-I Restriction in Nasopharyngeal Carcinoma Anti-Tumor Immunity.

Adv Sci (Weinh) · 2026 · PMC12955863 · PMID 41504259

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Both IFNγ and HK‐1 lysates upregulated the expression of MHC‐I but did not reach statistical significance in this assay (Figure S9C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

CD20&lt;sup&gt;+&lt;/sup&gt;FCRL4&lt;sup&gt;+&lt;/sup&gt; B Cells Activate CD8&lt;sup&gt;+&lt;/sup&gt; T Cells via MHC-I Restriction in Nasopharyngeal Carcinoma Anti-Tumor Immunity.

The sentences

CD20<sup>+</sup>FCRL4<sup>+</sup> B Cells Activate CD8<sup>+</sup> T Cells via MHC-I Restriction in Nasopharyngeal Carcinoma Anti-Tumor Immunity.